Edwards Lifesciences Debt to Equity Ratio Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 113.08  1.05  0.94%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Debt to Equity Ratio of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the ratio between Total Liabilities and Shareholders Equity.
View

34.5 %

            10 Years Trend  
Increasing
Slightly volatile
 Debt to Equity Ratio 
      Timeline 

Edwards Lifesciences Debt to Equity Ratio Over Time

2015-12-31  0.62 
2016-12-31  0.72 
2017-12-31  34.5 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  3.44
Geometric Mean  0.82
Coefficient Of Variation  284.35
Mean Deviation  5.18
Median  0.62
Standard Deviation  9.78
Sample Variance  95.71
Range  34.15
R Value  0.48
Mean Square Error  81.3
R Squared  0.23
Significance  0.12
Slope  1.29
Total Sum of Squares  1,053

Currently Trending

V   
 NYQ 
Purchased over 20 shares of
2 days ago ago
Traded for 107.02
GOOG   
 NMS 
Purchased few shares of
2 days ago ago
Traded for 984.45
VMW   
 NYQ 
Purchased over 20 shares of
2 days ago ago
Traded for 117.4